Correlation of cyclin D 1 and Rb gene expression with apoptosis in invasive breast cancer

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 1, 1998, Pages 30-34

  De Jong, J S ^a   Van Diest, P J ^a   Michalides, R J A M ^b   Van Der Valk, P ^a   Meijer, C J L M ^a   Baak, J P A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Apoptosis; Breast cancer; Cyclin D1; Histological grade; Histological type; Immunohistochemistry; Retinoblastoma susceptibility gene

Indexed keywords

CYCLIN D1; RETINOBLASTOMA PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CELL CYCLE G1 PHASE; CYTOGENETICS; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; BREAST TUMOR; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BREAST NEOPLASMS; CYCLIN D1; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN;

EID: 0031995120     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.1.30     Document Type: Article

References (56)

1. Lipponen P, Aaltomaa S, Kosma VM, et al. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994;30A:2068-73.
2. Clarke AR, Gledhill S, Hooper ML, et al. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation. Oncogen 1994;9:1767-73.
3. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Ocogene 1994;9:1799-805.
4. Strasser A, Harris AW, Jacks T, et al. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 1994;79:329-39.
5. Bargou RC, Daniel PT, Mapara MY, et al. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995;60:854-9.
6. Hanada M, Aime-Sempe C, Sato T, et al. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 1995; 270:11962-9.
7. Korsmeyer SJ, Shutter JR, Veis DJ, et al. Bcl-2 Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Sem Cancer Biol 1993;4:327-32.
8. Oltavi ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-12.
9. Chittenden T, Harrington EA, O'Connor R, et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995;374:733-6.
10. Farrow SN, White JH, Martinou I, et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995;374:731-3.
11. Kiefer MC, Brauer MJ, Powers VC, et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995;374:736-9.
12. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a Bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
13. Hockenberry DM, Oltavi ZN, Yin XM, et al. Bcl-2 functions in a antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
14. Vaux DL, Cory S, Adams TM. Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells, Nature 1988;335:440-2.
15. Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol 1993; 13:2432-40.
16. Bisonette RP, Echeverri F, Mahboubi A, et al. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359:552-4.
17. Karp JE, Broder S. Molecular foundations of cancer. New targets for intervention. Nat Med 1995;1:309-20.
18. Lukas J, Pagano M, Staskova Z, et al. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994;9:707-18.
19. Michalides R, Veelen N van, Hart A, et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res 1995;55:975-8.
20. Michalides R, Hageman PH, Tinteren H van, et al. A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 1996;73:728-34.
21. 1 to complete the cell cycle. Proc Natl Acad Sci USA 1994;91:8022-6.
22. Schuuring E, Verhoeven E, Mooi WJ, et al. Identification and cloning of two overexpressed genes, U21B31 PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992;7:355-61.
23. Schuuring E, Verhoeven E, Tinteren H van, et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992;52:5229-34.
24. Lammie G, Fantl V, Smith R, et al. D112287, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 1991;6:439-44.
25. Diest PJ van, Michalides RJAM, Jannink I, et al. Cyclin D1 expression in invasive breast cancer: correlations and prognostic value. Am J Pathol 1997;150:705-11.
26. Gillett C, Smith P, Gregory W, et al. Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996;69:92-9.
27. McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene 1995;11:885-91.
28. Worsley SD, Jennings BA, Khalil KH, et al. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression. J Clin Pathol: Mol Pathol 1996;49:M46-50.
29. Zukerberg LR, Yang WI, Gadd M, et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Pathol 1995;8:560-7.
30. Rosenberg CL, Kim HG, Shows TB, et al. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumours. Oncogene 1991;6:449-53.
31. Motokura T, Bloom T, Kim HG, et al. A novel cyclin encoded by a bcll-linked candidate oncogene. Nature 1991;350:512-15.
32. Freeman RS, Estus S, Johnson EM Jr. Analysis of cell cyclerelated gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron 1994;12:343-55.
33. Kranenburg O, van der Eb AJ, Zantema A. Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 1996;15:46-54.
34. Haas-Kogan DA, Kogan SC, Levi D, et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995;14:461-72.
35. Fan G, Ma X, Kren BT, et al. The retinoblastoma gene product inhibits TGF-betal induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996;12:1909-19.
36. Berry DH, Lu Y, Schmidt B, et al. Retinoblastoma protein inhibits IFN-gamma induced apoptosis. Oncogene 1996;12: 1809-19.
37. Haupt Y, Rowan S, Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRb. Oncongene 1995; 10:1563-71.
38. Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ, eds. Diagnostic histopathology of the breast Edinburgh: Churchill Livingstone, 1987:300-11.
39. Bartkova J, Lukas J, Müller H, et al. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994;57:353-61.
40. Schepop HAM, Jong JS de, Diest PJ van, et al. Counting of apoptotic cells: a methodological study in invasive breast cancer. J Clin Pathol: Mol Pathol 1996;49:M214-17.
41. Weisman JH, Jonker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
42. Zhang SY, Caamano J, Cooper F, et al. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-8.
43. Gillet C, Fantl V, Smith R, et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994;54:1812-17.
44. 1 phase in rodent fibroblasts. Genes Dev 1993;7:1559-71.
45. 1-to-S transition. Mol Cell Biol 1995;15: 3463-9.
46. Han EK-H, Sgambato A, Jiang W, et al. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995;10:953-61.
47. Pagano M, Theodoras AM, Tam SW, et al. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 1994;8:1627-39.
48. Trudel M, Mulligan L, Cavenee W, et al. Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1992;23:1388-94.
49. Pietilainen T, Lipponen P, Aaltomaa S, et al. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival, Eur J Cancer 1995;31A:329-33.
50. Borg Á, Zhang QX, Alm P, et al. The retinoblasoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 1992;52:2991-4.
51. Dublin EA, Barnes DM, Wang DY, et al. TGF alpha and TGF beta expression in mammary carcinoma. J Pathol 1993;179:15-22.
52. Mizukami Y, Nonomura A, Yamada T, et al. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I, and neu oncogene product in benign and malignant human breast tissues. Anticancer Res 1996;10:1115-26.
53. 1-phase control. Biol Chem Hist 1995;376:441-6.
54. Hermeking H, Eick D. Mediation of c-myc induced apoptosis by p53. Science 1994;265:2091-3.
55. Joensuu H, Pylkkanan L, Toikkanan S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-8.
56. Reynolds JE, Yang T, Qian L, et al, Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-myc overexpression in chinese hamster ovary cells. Cancer Res 1994;54:6348-52.